학술논문

Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC)
Document Type
Journal
Source
GYNECOLOGIC ONCOLOGY; AUG 2022, 166 pS98-pS98, 1p. Supplement: 1
Subject
Language
English
ISSN
10956859